Quality of life in Cushing's disease: a long term issue?

dc.contributor.authorWebb, S. M. (Susan M.), 1952-
dc.contributor.authorSantos Vives, Alicia
dc.contributor.authorResmini, Eugenia
dc.contributor.authorMartínez Momblán, Ma. Antonia
dc.contributor.authorMartel, Luciana
dc.contributor.authorValassi, Elena
dc.date.accessioned2018-12-05T13:05:27Z
dc.date.available2018-12-05T13:05:27Z
dc.date.issued2018-06
dc.date.updated2018-12-05T13:05:27Z
dc.description.abstractThe purpose of this review is to describe how quality of life (QoL) is impaired in patients with hypercortisolism due to Cushing's syndrome of any aetiology, including pituitary-dependent Cushing's disease. It is worse in active disease, but improvement after successful therapy is often incomplete, due to persistent physical and psychological co-morbidities, even years after endocrine "cure". Physical symptoms like extreme fatigability, central obesity with limb atrophy, hypertension, fractures, and different skin abnormalities severely impair the affected patients' everyday life. Psychological and cognitive problems like bad memory, difficulties to concentrate and emotional distress, often associated with anxiety and depression, make it difficult for many patients to overcome the aftermath of treated Cushing's syndrome. Recent studies have shown diffuse structural abnormalities in the central nervous system during active hyper-cortisolism, thought to be related to the wide distribution of glucocorticoid receptors throughout the brain. Even though they improve after treatment, normalization is often not complete. Shortening the exposure to active Cushing's syndrome by reducing the often long delay to diagnosis and promptly receiving effective treatment is highly desirable, together with preparing the patient for the difficult periods, especially after surgery. In this way they are prepared for the impairments they perceive in every day life, and live with the hope of later improvement, which can be therapeutic in many instances.
dc.format.extent6 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec683333
dc.identifier.issn0003-4266
dc.identifier.pmid29625700
dc.identifier.urihttps://hdl.handle.net/2445/126753
dc.language.isoeng
dc.publisherElsevier Masson SAS
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.ando.2018.03.007
dc.relation.ispartofAnnales d'Endocrinologie, 2018, vol. 79, num. 3, p. 132-137
dc.relation.urihttps://doi.org/10.1016/j.ando.2018.03.007
dc.rights(c) Elsevier Masson SAS, 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Infermeria Fonamental i Clínica)
dc.subject.classificationQualitat de vida
dc.subject.classificationComorbiditat
dc.subject.classificationAnsietat
dc.subject.classificationSíndrome de Cushing
dc.subject.otherQuality of life
dc.subject.otherComorbidity
dc.subject.otherAnxiety
dc.subject.otherCushing's syndrome
dc.titleQuality of life in Cushing's disease: a long term issue?
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
683333.pdf
Mida:
980.5 KB
Format:
Adobe Portable Document Format